Campbell & CO Investment Adviser LLC Iovance Biotherapeutics, Inc. Transaction History

Campbell & CO Investment Adviser LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.78 - $14.19 $873,515 - $1.59 Million	112,277 New	112,277 $900,000
Q4 2021 Feb 10, 2022	SELL	$16.55 - $27.63 $168,810 - $281,826	-10,200 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$20.35 - $26.63 $207,570 - $271,626	10,200 New	10,200 $252,000

318

242M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $963M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.